Form D · Biotechnology
4DMedical Ltd
Carlton, C3 · CIK 0002075735
Offering snapshot reported Jul 7, 2025 · SEC filing
- Reported sold
- $15M Offering amount: $15M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $325 Reported outside-investor minimum
- First sale
- May 29, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 7, 2025 | Initial | $14,964,623 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-550882
Source: Form D, filed Jul 7, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Lillian Bianchi | Director |
| Robert Alan Figlin | Director |
| Andreas Christos Fouras | Director, Executive |
| John Andrew Livingston | Director |
| Geraldine Bernadette Mc Ginty | Director |
| Julian Bernard Kingsley Sutton | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
Level 7 700 Swanston Street
Carlton, C3, VIC 3053
Carlton, C3, VIC 3053